ITAT Ahmedabad Upholds CIT(A) Decisions on Revenue's Disallowances

The appeal filed by the Revenue was dismissed by ITAT Ahmedabad, upholding the CIT(A)'s decisions on various disallowances related to physician samples, sponsorship of doctors' tours, sales promotion expenses, and deduction u/s 54EC. The court relied on judicial precedents and reasoned that the expenses were business-related and necessary for promoting the assessee's products, consistent with previous rulings in similar cases.

---

---

Issues Involved:
1. Disallowance of Rs. 1,42,44,447/- on account of physician samples distributed free of cost.
2. Disallowance of Rs. 1,17,53,365/- on account of sponsorship of doctors' overseas tours.
3. Disallowance of Rs. 61,28,797/- on account of sales promotion expenses.
4. Consideration of Board's Circular No. 5/2012.
5. Disallowance of Rs. 50,00,000/- by rejecting the assessee's claim of deduction u/s 54EC.

Issue-wise Detailed Analysis:

1. Disallowance of Rs. 1,42,44,447/- on account of physician samples distributed free of cost:
The Assessing Officer (A.O.) disallowed Rs. 1,42,44,447/- being 70% of Rs. 2,03,49,211/- for physician samples distributed free of cost, treating it as non-business expenditure. The assessee appealed, and the CIT(A) accepted the contention, referencing an identical issue decided in favor of the assessee by ITAT Mumbai for A.Y. 2008-09. The Gujarat High Court also upheld this view, noting that free samples are a business promotion activity and the genuineness of transactions was not doubted. Consequently, the appeal of the Revenue was dismissed by ITAT Ahmedabad, following judicial consistency.

2. Disallowance of Rs. 1,17,53,365/- on account of sponsorship of doctors' overseas tours:
The A.O. disallowed Rs. 1,17,53,365/- based on CBDT Circular No. 5/2012, which prohibits medical practitioners from accepting gifts or travel facilities from pharmaceutical companies. The CIT(A) granted relief, referencing ITAT Mumbai's decision in the assessee's favor for A.Y. 2008-09, which held that such sponsorships, although potentially unethical for doctors, were business expenses for the assessee aimed at promoting their products. ITAT Ahmedabad upheld this decision, dismissing the Revenue's appeal.

3. Disallowance of Rs. 61,28,797/- on account of sales promotion expenses:
The A.O. disallowed Rs. 61,28,797/- for sales promotion, including gifts to doctors, scientific promotional articles, and dermatology books, arguing these were not allowable under Section 37 of the Income Tax Act. The CIT(A) allowed the appeal, stating these expenses were integral to the business and incurred out of commercial expediency. The CIT(A) noted the expenses were not personal or capital in nature and facilitated business operations. ITAT Ahmedabad upheld this view, affirming the CIT(A)'s detailed and reasoned order.

4. Consideration of Board's Circular No. 5/2012:
The A.O. referenced Circular No. 5/2012 in disallowing expenses related to doctors' overseas tours and sales promotion. However, CIT(A) and ITAT Ahmedabad found that the expenditures were business-related and necessary for promoting the assessee's products, thereby allowing the expenses despite the circular.

5. Disallowance of Rs. 50,00,000/- by rejecting the assessee's claim of deduction u/s 54EC:
The A.O. disallowed the deduction u/s 54EC against deemed Short Term Capital Gain, arguing it was not allowable. The CIT(A) allowed the claim, referencing the Gujarat High Court's decision in CIT vs. Aditya Medisales, which held that exemption under Section 54EC could not be denied if the capital gain arose from a long-term asset and was invested in specified assets. ITAT Ahmedabad upheld this decision, finding no reason to interfere with the CIT(A)'s detailed and reasoned order.

Conclusion:
The appeal filed by the Revenue was dismissed on all grounds, with ITAT Ahmedabad upholding the CIT(A)'s decisions, which were based on judicial precedents and detailed reasoning. The assessments were found to be consistent with previous rulings in similar cases, affirming the business nature of the disputed expenditures.

---